Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout.

Cancers·2025
Same author

Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Dedifferentiated Solitary Fibrous Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Characterization of 25 Cases.

The American journal of surgical pathology·2025
Same author

Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcoma.

Oncology letters·2025
Same author

The activated tyrosine kinase ACK1 by multiple receptor tyrosine kinases promotes proliferation and invasion of mesothelioma via regulation of PI3K/AKT/mTOR and RAF/MAPK signaling pathways.

Cancer gene therapy·2025
Same author

Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024).

Geburtshilfe und Frauenheilkunde·2025
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
查看所有相关文章

相关实验视频

Updated: Jul 10, 2025

Single Molecule Analysis of Laser Localized Psoralen Adducts
11:46

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

6.7K

准的是DNA-PK.

Jan Philipp Novotny1, Adrian Mariño-Enríquez2, Jonathan A Fletcher2

  • 1Department of Pathology, Brigham and Women's Hospital, Boston, USA. JanPhilipp.Novotny@med.uni-heidelberg.de.

Cancer treatment and research
|November 17, 2023
PubMed
概括
此摘要是机器生成的。

DNA激活蛋白激酶 (DNA-PK) 对于DNA修复和其他过程至关重要. 了解其复杂的作用为癌症治疗提供了新的途径,但也为组合疗法带来了挑战.

关键词:
造成的DNA损伤是DNA损伤.这就是DNA-PKK.豁免权是一种豁免权.这就是NHEJJ.治疗疗法 治疗疗法

更多相关视频

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.3K
Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation
12:29

Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation

Published on: March 20, 2018

9.5K

相关实验视频

Last Updated: Jul 10, 2025

Single Molecule Analysis of Laser Localized Psoralen Adducts
11:46

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

6.7K
Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.3K
Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation
12:29

Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation

Published on: March 20, 2018

9.5K

科学领域:

  • 分子生物学分子生物学
  • 遗传学 是一个遗传学.
  • 癌症研究 癌症研究

背景情况:

  • DNA激活蛋白激酶 (DNA-PK) 是DNA修复途径的关键调节者.
  • 非同源端结合 (NHEJ) 是一种主要的DNA双链断裂修复机制,由DNA-PK.主导.
  • 新出现的证据表明,DNA-PK参与了DNA修复之外的各种生物过程.

研究的目的:

  • 探索DNA-PK的多方面的作用.
  • 专注于DNA-PK在非同源端结合 (NHEJ) DNA修复中的功能.
  • 讨论DNA-PK在癌症治疗中的不同作用的含义.

主要方法:

  • 文献综述和对DNA-PK的当前研究的综合.
  • 对DNA-PK参与NHEJ和其他细胞功能的分析.
  • 讨论临床翻译的挑战和机遇.

主要成果:

  • DNA-PK被证实是NHEJ的中央编排者.
  • DNA-PK 调节了多种生物过程,超出了它在DNA修复中的正规作用.
  • DNA-PK 的多样性功能既为新型癌症治疗提供了机会,也为组合疗法带来了潜在的挑战.

结论:

  • DNA-PK的复杂生物作用为癌症治疗策略提供了有前途的新途径.
  • 临床转化中的挑战,包括潜在的毒性,需要创新的治疗方法.
  • 需要进一步的研究,以有效地利用DNA-PK的治疗潜力,同时降低风险.